Yuanchang Ma

Title: Innovations of Yuanchang Ma in Pharmaceutical Preparations

Introduction

Yuanchang Ma is a notable inventor based in Jinan, China. He has made significant contributions to the field of pharmaceutical preparations, particularly through his innovative methods in crystallization. His work has implications for the efficiency and purity of pharmaceutical compounds.

Latest Patents

Yuanchang Ma holds a patent for a method titled "Method for preparing esomeprazole magnesium trihydrate by crystal transformation." This invention discloses a novel approach to preparing esomeprazole magnesium trihydrate, which is crucial in the pharmaceutical industry. The method involves preparing an esomeprazole potassium aqueous solution and a magnesium sulfate heptahydrate aqueous solution, followed by a reactive crystallization process. This process results in the formation of esomeprazole magnesium tetrahydrate, which is then filtered to obtain a sphaerocrystal of esomeprazole magnesium trihydrate. Notably, the entire process takes only about one hour, significantly reducing the reaction time while ensuring high purity and good fluidity of the final product.

Career Highlights

Yuanchang Ma is associated with the Shandong Analysis and Test Center, where he applies his expertise in pharmaceutical preparations. His innovative methods have the potential to enhance the efficiency of drug manufacturing processes. His work is characterized by a focus on improving the quality and performance of pharmaceutical compounds.

Collaborations

Yuanchang Ma has collaborated with notable colleagues, including Fumin Xue and Shuai Yu. These collaborations have likely contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Yuanchang Ma's contributions to the field of pharmaceutical preparations through his innovative methods demonstrate his commitment to enhancing drug manufacturing processes. His patent for preparing esomeprazole magnesium trihydrate showcases the potential for improved efficiency and purity in pharmaceuticals.